Monthly
US$200
Billed every month
Azithromycin For Injection(注射用阿奇霉素)
Companies, stages and changes, with each record available on this page.
Last 90 days: Accepted: 4 applications
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Company names, approval identifiers and strengths are retained as recorded in the Chinese sources. Category labels include the original wording for verification.
Catalogue holders34View records ↓
Under-review filings11View records ↓
This year’s generic filers2View records ↓
NHSA approval numbers125View records ↓
API companies with A status34View records ↓
Chemical-drug catalogue
Loaded records: 34 holders; 24 in the quality-and-efficacy consistency-evaluation category, and 9 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| 瑞阳制药股份有限公司 | 瑞阳制药股份有限公司 | 国药准字H20066472 | 2026/07/02 | 0.5g（按C38H72N2O12计） | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 南京海纳医药科技股份有限公司 | 南京海纳制药有限公司 | 国药准字H20264095 | 2026/04/21 | 0.5g（按C38H72N2O12计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 长春海悦药业股份有限公司 | 长春海悦药业股份有限公司 | 国药准字H20213102 | 2025/08/27 | 0.5g（按C38H72N2O12计） | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 海南斯达制药有限公司 | 海南斯达制药有限公司 | 国药准字H20254211 | 2025/05/20 | 0.5g（按C38H72N2O12计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 国药集团容生制药有限公司 | 国药集团容生制药有限公司 | 国药准字H20244688 | 2024/08/20 | 0.5g（按 C38H72N2O12计 ） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江苏金丝利药业股份有限公司 | 江苏金丝利药业股份有限公司 | 国药准字H20030164 | 2024/05/08 | 0.5g(按C38H72N2O12计) | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 东药集团沈阳施德药业有限公司 | 东北制药集团沈阳第一制药有限公司 | 国药准字H20243582 | 2024/04/24 | 0.5g（按C38H72N2O12计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 齐鲁制药有限公司 | 齐鲁制药有限公司 | 国药准字H20237135 | 2023/10/27 | 0.5g（按C38H72N2O12计） | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 华北制药股份有限公司 | 华北制药股份有限公司 | 国药准字H20237127 | 2023/10/24 | 0.5g（按C38H72N2O12计） | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 陕西博森生物制药股份集团有限公司 | 陕西博森生物制药股份集团有限公司 | 国药准字H20234287 | 2023/10/12 | 0.5g（按C38H72N2O12计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 上海上药新亚药业有限公司 | 上海上药新亚药业有限公司 | 国药准字H20056283 | 2023/08/21 | 0.5g（按C38H72N2O12计） | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 峨眉山通惠制药有限公司 | 峨眉山通惠制药有限公司 | 国药准字H20066566 | 2023/08/11 | 0.5g（按C38H72N2O12计） | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 石家庄四药有限公司 | 河北爱尔海泰制药有限公司 | 国药准字H20067807 | 2023/03/21 | 0.5g(按C38H72N2O12计) | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 湖北科益药业股份有限公司 | 湖北科益药业股份有限公司 | 国药准字H20066572 | 2023/02/20 | 0.5g（按C38H72N2O12计） | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 浙江金华康恩贝生物制药有限公司 | 浙江金华康恩贝生物制药有限公司 | 国药准字H20040447 | 2023/02/15 | 0.5g（按C38H72N2O12计） | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 吉林津升制药有限公司 | 吉林津升制药有限公司 | 国药准字H20223790 | 2022/11/01 | 0.5g（按C38H72N2O12计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东海雅医药科技有限公司 | 山东齐都药业有限公司 | 国药准字H20223740 | 2022/10/11 | 0.5g（按C38H72N2O12计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 安徽省先锋制药有限公司 | 安徽省先锋制药有限公司 | 国药准字H20073807 | 2022/10/08 | 0.5g（按C38H72N2012计） | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 悦康药业集团股份有限公司 | 悦康药业集团股份有限公司 | 国药准字H20094017 | 2022/07/22 | 0.5g（按C38H72N2O12计） | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 浙江亚太药业股份有限公司 | 浙江亚太药业股份有限公司 | 国药准字H20063286 | 2022/03/28 | 0.5g（按C38H72N2O12计） | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 湖南恒生制药股份有限公司 | 湖南恒生制药股份有限公司 | 国药准字H20227038 | 2022/03/21 | 0.5g（按C38H72N2O12计） | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 湖南科伦制药有限公司 | 湖南科伦制药有限公司 | 国药准字H20063421 | 2021/12/24 | 0.5g（按C38H72N2O12计） | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 成都天台山制药有限公司 | 成都天台山制药有限公司 | 国药准字H20064851 | 2021/12/08 | 0.5g（按C38H72N2O12计） | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 湖北潜龙药业有限公司 | 湖北潜龙药业有限公司 | 国药准字H20044550 | 2021/11/23 | 0.5g（按C38H72N2O12计） | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 海南葫芦娃药业集团股份有限公司 | 海南葫芦娃药业集团股份有限公司 | 国药准字H20064932 | 2021/11/19 | 0.5g（按C38H72N2O12计） | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 江苏吴中医药集团有限公司苏州制药厂 | 江苏吴中医药集团有限公司苏州制药厂 | 国药准字H20217110 | 2021/11/11 | 0.5g（按C38H72N2O12计） | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 南京圣和药业股份有限公司 | 南京圣和药业股份有限公司 | 国药准字H20213559 | 2021/06/29 | 0.5g(按C38H72N2O12计) | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 舒美奇成都生物科技有限公司 | 成都通德药业有限公司 | 国药准字H20213445 | 2021/06/01 | 按C38H72N2O12计 0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 海南海灵化学制药有限公司 | 海南海灵化学制药有限公司 | 国药准字H20020254 | 2021/05/24 | 0.5g（按C38H72N2O12计） | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 海南倍特药业有限公司 | 海南倍特药业有限公司 | 国药准字H20067075 | 2021/03/22 | 0.5g（按C38H72N2O12计） | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 国药集团国瑞药业有限公司 | 国药集团国瑞药业有限公司 | 国药准字H20030269 | 2021/02/07 | 0.5g（按C38H72N2O12计） | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 石药集团欧意药业有限公司 | 石药集团欧意药业有限公司 | 国药准字H20050099 | 2021/01/26 | 0.5g(按C38H72N2O12计) | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 海南普利制药股份有限公司 | 国药准字H20173261 | 2018/05/15 | 0.5g(按C38H72N2O12计) | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| Pfizer Inc. | Pharmacia & Upjohn Company LLC | H20130830;H20140685;H20130831 | 2004/10/09 | 0.5g | Imported originator drug (进口原研药品) | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 125 distinct approval numbers and 66 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| 广东星昊药业有限公司 | 国药准字H20066439 | 0.125g | Category B (乙) | XJ01FAA051B001010100198 | NHSA |
| 深圳海王药业有限公司 | 国药准字H20064349 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B001010100503 | NHSA |
| 上海上药新亚药业有限公司 | 国药准字H20030249 | 按C38H72N2O12计 0.125g | Category B (乙) | XJ01FAA051B001010100792 | NHSA |
| 东药集团沈阳施德药业有限公司 | 国药准字H20243582 | 0.5g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001010101317 | NHSA |
| 沈阳药大雷允上药业有限责任公司 | 国药准字H20066411 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B001010101333 | NHSA |
| 江苏金丝利药业股份有限公司 | 国药准字H19990384 | 0.125g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001010101459 | NHSA |
| 江苏吴中医药集团有限公司苏州制药厂 | 国药准字H20065029 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B001010101504 | NHSA |
| 南京海辰药业股份有限公司 | 国药准字H20050311 | 0.25g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001010101563 | NHSA |
| 南京圣和药业股份有限公司 | 国药准字H20000328 | 0.125g(12.5万单位) | Category B (乙) | XJ01FAA051B001010101583 | NHSA |
| 湖北荷普药业有限公司 | 国药准字H20064561 | 按C38H72N2O12计0.25g | Category B (乙) | XJ01FAA051B001010101807 | NHSA |
| 湖北科益药业股份有限公司 | 国药准字H20066571 | 0.25g | Category B (乙) | XJ01FAA051B001010101828 | NHSA |
| 湖北潜龙药业有限公司 | 国药准字H20044560 | 0.1g | Category B (乙) | XJ01FAA051B001010101841 | NHSA |
| 湖北午时药业股份有限公司 | 国药准字H20066929 | 0.1g(按C38H72N2012计) | Category B (乙) | XJ01FAA051B001010101874 | NHSA |
| 湖北长联杜勒制药有限公司 | 国药准字H20163218 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B001010101929 | NHSA |
| 宜昌东阳光长江药业股份有限公司 | 国药准字H20093665 | 0.25g | Category B (乙) | XJ01FAA051B001010101997 | NHSA |
| 舒美奇成都生物科技有限公司 | 国药准字H20213445 | 按C38H72N2O12计0.5g | Category B (乙) | XJ01FAA051B001010102068 | NHSA |
| 峨眉山通惠制药有限公司 | 国药准字H20066168 | 0.125g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001010102092 | NHSA |
| 陕西博森生物制药股份集团有限公司 | 国药准字H20234287 | 0.5g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001010102357 | NHSA |
| 西安利君制药有限责任公司 | 国药准字H20010118 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B001010102503 | NHSA |
| 石家庄四药有限公司 | 国药准字H20067808 | 0.25g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001010102557 | NHSA |
| 华北制药股份有限公司 | 国药准字H20237127 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001010102690 | NHSA |
| 华北制药股份有限公司 | 国药准字H20066141 | 按C₃₈H₇₂N₂O₁₂计0.125g | Category B (乙) | XJ01FAA051B001010102699 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20050098 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B001010102770 | NHSA |
| 河南辅仁怀庆堂制药有限公司 | 国药准字H20068127 | 0.125g | Category B (乙) | XJ01FAA051B001010103010 | NHSA |
| 河南辅仁怀庆堂制药有限公司 | 国药准字H20020530 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B001010103021 | NHSA |
| 开封康诺药业有限公司 | 国药准字H20065172 | 0.125g(12.5万单位) | Category B (乙) | XJ01FAA051B001010103134 | NHSA |
| 国药集团容生制药有限公司 | 国药准字H20244688 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001010103205 | NHSA |
| 长春海悦药业股份有限公司 | 国药准字H20213102 | 按C₃₈H₇₂N₂O₁₂计0.5g | Category B (乙) | XJ01FAA051B001010103307 | NHSA |
| 山东海雅医药科技有限公司 | 国药准字H20223740 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001010104145 | NHSA |
| 安徽威尔曼制药有限公司 | 国药准字H20065830 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B001010104354 | NHSA |
| 杭州国光药业股份有限公司 | 国药准字H20073622 | 0.125g(12.5万单位) | Category B (乙) | XJ01FAA051B001010104478 | NHSA |
| 浙江贝得药业有限公司 | 国药准字H20065690 | 0.25g | Category B (乙) | XJ01FAA051B001010104612 | NHSA |
| 浙江金华康恩贝生物制药有限公司 | 国药准字H20040447 | 0.5g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001010104656 | NHSA |
| 浙江华润三九众益制药有限公司 | 国药准字H20094119 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B001010104676 | NHSA |
| 浙江亚太药业股份有限公司 | 国药准字H20063285 | 0.125g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001010104744 | NHSA |
| 浙江佐力药业股份有限公司 | 国药准字H20074176 | 0.25g | Category B (乙) | XJ01FAA051B001010104761 | NHSA |
| 湖南恒生制药股份有限公司 | 国药准字H20066937 | 0.25g按C38H72N2O12计 | Category B (乙) | XJ01FAA051B001010104900 | NHSA |
| 湖南科伦制药有限公司 | 国药准字H20063420 | 按C₃₈H₇₂N₂O₁₂计0.25g | Category B (乙) | XJ01FAA051B001010105006 | NHSA |
| 海南葫芦娃药业集团股份有限公司 | 国药准字H20064932 | 0.5g(按C₃₈H₇₂N₂0₁₂计) | Category B (乙) | XJ01FAA051B001010105754 | NHSA |
| 海南倍特药业有限公司 | 国药准字H20066155 | 按C₃₈H₇₂N₂O₁₂计0.1g | Category B (乙) | XJ01FAA051B001010105791 | NHSA |
| 海南普利制药股份有限公司 | 国药准字H20173261 | 0.5g | Category B (乙) | XJ01FAA051B001010105801 | NHSA |
| 海南双成药业股份有限公司 | 国药准字H20074128 | 0.5g(50万单位) | Category B (乙) | XJ01FAA051B001010105814 | NHSA |
| 康芝药业股份有限公司 | 国药准字H20067868 | 0.125g(12.5万单位) | Category B (乙) | XJ01FAA051B001010105844 | NHSA |
| 吉林津升制药有限公司 | 国药准字H20223790 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001010109871 | NHSA |
| Pfizer Inc. | 国药准字HJ20130830 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001010178718 | NHSA |
| 南京海纳医药科技股份有限公司 | 国药准字H20264095 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001010183242 | NHSA |
| 广东星昊药业有限公司 | 国药准字H20066439 | 0.125g | Category B (乙) | XJ01FAA051B001010200198 | NHSA |
| 上海上药新亚药业有限公司 | 国药准字H20030249 | 按C38H72N2O12计 0.125g | Category B (乙) | XJ01FAA051B001010200792 | NHSA |
| 东药集团沈阳施德药业有限公司 | 国药准字H20243582 | 0.5g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001010201317 | NHSA |
| 江苏金丝利药业股份有限公司 | 国药准字H19990384 | 0.125g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001010201459 | NHSA |
| 南京海辰药业股份有限公司 | 国药准字H20050311 | 0.25g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001010201563 | NHSA |
| 南京圣和药业股份有限公司 | 国药准字H20000328 | 0.125g(12.5万单位) | Category B (乙) | XJ01FAA051B001010201583 | NHSA |
| 湖北荷普药业有限公司 | 国药准字H20064561 | 按C38H72N2O12计0.25g | Category B (乙) | XJ01FAA051B001010201807 | NHSA |
| 湖北科益药业股份有限公司 | 国药准字H20066571 | 0.25g | Category B (乙) | XJ01FAA051B001010201828 | NHSA |
| 湖北潜龙药业有限公司 | 国药准字H20044560 | 0.1g | Category B (乙) | XJ01FAA051B001010201841 | NHSA |
| 湖北午时药业股份有限公司 | 国药准字H20066929 | 0.1g(按C38H72N2012计) | Category B (乙) | XJ01FAA051B001010201874 | NHSA |
| 湖北长联杜勒制药有限公司 | 国药准字H20163218 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B001010201929 | NHSA |
| 宜昌东阳光长江药业股份有限公司 | 国药准字H20093665 | 0.25g | Category B (乙) | XJ01FAA051B001010201997 | NHSA |
| 舒美奇成都生物科技有限公司 | 国药准字H20213445 | 按C38H72N2O12计0.5g | Category B (乙) | XJ01FAA051B001010202068 | NHSA |
| 峨眉山通惠制药有限公司 | 国药准字H20066168 | 0.125g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001010202092 | NHSA |
| 陕西博森生物制药股份集团有限公司 | 国药准字H20234287 | 0.5g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001010202357 | NHSA |
| 华北制药股份有限公司 | 国药准字H20066141 | 按C₃₈H₇₂N₂O₁₂计0.125g | Category B (乙) | XJ01FAA051B001010202699 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20050098 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B001010202770 | NHSA |
| 河南辅仁怀庆堂制药有限公司 | 国药准字H20068127 | 0.125g | Category B (乙) | XJ01FAA051B001010203010 | NHSA |
| 河南辅仁怀庆堂制药有限公司 | 国药准字H20020530 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B001010203021 | NHSA |
| 开封康诺药业有限公司 | 国药准字H20065172 | 0.125g(12.5万单位) | Category B (乙) | XJ01FAA051B001010203134 | NHSA |
| 国药集团容生制药有限公司 | 国药准字H20244688 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001010203205 | NHSA |
| 长春海悦药业股份有限公司 | 国药准字H20213102 | 按C₃₈H₇₂N₂O₁₂计0.5g | Category B (乙) | XJ01FAA051B001010203307 | NHSA |
| 哈尔滨圣泰生物制药有限公司 | 国药准字H20073678 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B001010203665 | NHSA |
| 山东海雅医药科技有限公司 | 国药准字H20223740 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001010204145 | NHSA |
| 安徽威尔曼制药有限公司 | 国药准字H20065830 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B001010204354 | NHSA |
| 浙江贝得药业有限公司 | 国药准字H20065690 | 0.25g | Category B (乙) | XJ01FAA051B001010204612 | NHSA |
| 浙江金华康恩贝生物制药有限公司 | 国药准字H20040447 | 0.5g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001010204656 | NHSA |
| 湖南科伦制药有限公司 | 国药准字H20063420 | 按C₃₈H₇₂N₂O₁₂计0.25g | Category B (乙) | XJ01FAA051B001010205006 | NHSA |
| 海南葫芦娃药业集团股份有限公司 | 国药准字H20064932 | 0.5g(按C₃₈H₇₂N₂0₁₂计) | Category B (乙) | XJ01FAA051B001010205754 | NHSA |
| 海南海灵化学制药有限公司 | 国药准字H20000082 | 0.125g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001010205776 | NHSA |
| 海南普利制药股份有限公司 | 国药准字H20173261 | 0.5g | Category B (乙) | XJ01FAA051B001010205801 | NHSA |
| 海南双成药业股份有限公司 | 国药准字H20074128 | 0.5g(50万单位) | Category B (乙) | XJ01FAA051B001010205814 | NHSA |
| 四川宏明博思药业有限公司 | 国药准字H20093666 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B001010206725 | NHSA |
| 吉林津升制药有限公司 | 国药准字H20223790 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001010209871 | NHSA |
| Pfizer Inc. | 国药准字HJ20130830 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001010278718 | NHSA |
| 江苏金丝利药业股份有限公司 | 国药准字H19990384 | 0.125g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001010301459 | NHSA |
| 南京海辰药业股份有限公司 | 国药准字H20050311 | 0.25g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001010301563 | NHSA |
| 南京圣和药业股份有限公司 | 国药准字H20000328 | 0.125g(12.5万单位) | Category B (乙) | XJ01FAA051B001010301583 | NHSA |
| 华北制药股份有限公司 | 国药准字H20066141 | 按C₃₈H₇₂N₂O₁₂计0.125g | Category B (乙) | XJ01FAA051B001010302699 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20050098 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B001010302770 | NHSA |
| 河南辅仁怀庆堂制药有限公司 | 国药准字H20068127 | 0.125g | Category B (乙) | XJ01FAA051B001010303010 | NHSA |
| 开封康诺药业有限公司 | 国药准字H20065172 | 0.125g(12.5万单位) | Category B (乙) | XJ01FAA051B001010303134 | NHSA |
| 长春海悦药业股份有限公司 | 国药准字H20213102 | 按C₃₈H₇₂N₂O₁₂计0.5g | Category B (乙) | XJ01FAA051B001010303307 | NHSA |
| 哈尔滨圣泰生物制药有限公司 | 国药准字H20073678 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B001010303665 | NHSA |
| 海南海灵化学制药有限公司 | 国药准字H20000082 | 0.125g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001010305776 | NHSA |
| 四川宏明博思药业有限公司 | 国药准字H20093666 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B001010306725 | NHSA |
| 江苏金丝利药业股份有限公司 | 国药准字H19990384 | 0.125g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001010401459 | NHSA |
| 江苏金丝利药业股份有限公司 | 国药准字H19990384 | 0.125g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001010501459 | NHSA |
| 广东星昊药业有限公司 | 国药准字H20066440 | 0.25g | Category B (乙) | XJ01FAA051B001020100198 | NHSA |
| 上海上药新亚药业有限公司 | 国药准字H20030248 | 按C38H72N2O12计 0.25g | Category B (乙) | XJ01FAA051B001020100792 | NHSA |
| 江苏金丝利药业股份有限公司 | 国药准字H19990385 | 0.25g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001020101459 | NHSA |
| 南京圣和药业股份有限公司 | 国药准字H20000329 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B001020101583 | NHSA |
| 扬子江药业集团有限公司 | 国药准字H20213377 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001020101749 | NHSA |
| 湖北科益药业股份有限公司 | 国药准字H20066572 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001020101828 | NHSA |
| 湖北潜龙药业有限公司 | 国药准字H19990136 | 0.25g | Category B (乙) | XJ01FAA051B001020101841 | NHSA |
| 峨眉山通惠制药有限公司 | 国药准字H20066565 | 0.25g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001020102092 | NHSA |
| 西安利君制药有限责任公司 | 国药准字H20020269 | 0.5g(50万单位) | Category B (乙) | XJ01FAA051B001020102503 | NHSA |
| 石家庄四药有限公司 | 国药准字H20067807 | 0.5g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001020102557 | NHSA |
| 华北制药股份有限公司 | 国药准字H20066581 | 按C₃₈H₇₂N₂O₁₂计0.25g | Category B (乙) | XJ01FAA051B001020102699 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20050099 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001020102770 | NHSA |
| 晋城海斯制药有限公司 | 国药准字H20065482 | 0.5g | Category B (乙) | XJ01FAA051B001020102856 | NHSA |
| 河南辅仁怀庆堂制药有限公司 | 国药准字H20041623 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001020103021 | NHSA |
| 开封康诺药业有限公司 | 国药准字H20065174 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B001020103134 | NHSA |
| 杭州国光药业股份有限公司 | 国药准字H20073623 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B001020104478 | NHSA |
| 浙江贝得药业有限公司 | 国药准字H20073769 | 按C38H72N2O12计 0.125g | Category B (乙) | XJ01FAA051B001020104612 | NHSA |
| 浙江华润三九众益制药有限公司 | 国药准字H20094120 | 0.5g(50万单位) | Category B (乙) | XJ01FAA051B001020104676 | NHSA |
| 浙江亚太药业股份有限公司 | 国药准字H20063284 | 0.25g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001020104744 | NHSA |
| 湖南恒生制药股份有限公司 | 国药准字H20227038 | 0.5g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001020104900 | NHSA |
| 湖南科伦制药有限公司 | 国药准字H20063421 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001020105006 | NHSA |
| 海南倍特药业有限公司 | 国药准字H20067074 | 0.25g (按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001020105791 | NHSA |
| 康芝药业股份有限公司 | 国药准字H20067869 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B001020105844 | NHSA |
| 四川宏明博思药业有限公司 | 国药准字H20093667 | 0.5g(50万单位) | Category B (乙) | XJ01FAA051B001020106725 | NHSA |
| 南京海纳制药有限公司 | 国药准字H20093636 | 0.125g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001020106908 | NHSA |
| 南京海纳医药科技股份有限公司 | 国药准字H20264095 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001020183242 | NHSA |
| 广东星昊药业有限公司 | 国药准字H20066440 | 0.25g | Category B (乙) | XJ01FAA051B001020200198 | NHSA |
| 上海上药新亚药业有限公司 | 国药准字H20030248 | 按C38H72N2O12计 0.25g | Category B (乙) | XJ01FAA051B001020200792 | NHSA |
| 江苏金丝利药业股份有限公司 | 国药准字H19990385 | 0.25g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001020201459 | NHSA |
| 苏州朗易生物医药研究有限公司 | 国药准字H20217110 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001020201504 | NHSA |
| 南京圣和药业股份有限公司 | 国药准字H20000329 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B001020201583 | NHSA |
| 扬子江药业集团有限公司 | 国药准字H20213377 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001020201749 | NHSA |
| 湖北科益药业股份有限公司 | 国药准字H20066572 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001020201828 | NHSA |
| 湖北潜龙药业有限公司 | 国药准字H19990136 | 0.25g | Category B (乙) | XJ01FAA051B001020201841 | NHSA |
| 峨眉山通惠制药有限公司 | 国药准字H20066565 | 0.25g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001020202092 | NHSA |
| 华北制药股份有限公司 | 国药准字H20066581 | 按C₃₈H₇₂N₂O₁₂计0.25g | Category B (乙) | XJ01FAA051B001020202699 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20050099 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001020202770 | NHSA |
| 河南辅仁怀庆堂制药有限公司 | 国药准字H20041623 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001020203021 | NHSA |
| 开封康诺药业有限公司 | 国药准字H20065174 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B001020203134 | NHSA |
| 湖南恒生制药股份有限公司 | 国药准字H20227038 | 0.5g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001020204900 | NHSA |
| 海南海灵化学制药有限公司 | 国药准字H20000083 | 0.25g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001020205776 | NHSA |
| 四川宏明博思药业有限公司 | 国药准字H20093667 | 0.5g(50万单位) | Category B (乙) | XJ01FAA051B001020206725 | NHSA |
| 南京海纳制药有限公司 | 国药准字H20093636 | 0.125g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001020206908 | NHSA |
| 上海上药新亚药业有限公司 | 国药准字H20030248 | 按C38H72N2O12计 0.25g | Category B (乙) | XJ01FAA051B001020300792 | NHSA |
| 苏州朗易生物医药研究有限公司 | 国药准字H20217110 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001020301504 | NHSA |
| 南京圣和药业股份有限公司 | 国药准字H20000329 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B001020301583 | NHSA |
| 华北制药股份有限公司 | 国药准字H20066581 | 按C₃₈H₇₂N₂O₁₂计0.25g | Category B (乙) | XJ01FAA051B001020302699 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20050099 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001020302770 | NHSA |
| 河南辅仁怀庆堂制药有限公司 | 国药准字H20041623 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001020303021 | NHSA |
| 海南海灵化学制药有限公司 | 国药准字H20000083 | 0.25g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001020305776 | NHSA |
| 南京海纳制药有限公司 | 国药准字H20093636 | 0.125g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001020306908 | NHSA |
| 上海上药新亚药业有限公司 | 国药准字H20030248 | 按C38H72N2O12计 0.25g | Category B (乙) | XJ01FAA051B001020400792 | NHSA |
| 苏州朗易生物医药研究有限公司 | 国药准字H20217110 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001020401504 | NHSA |
| 南京海纳制药有限公司 | 国药准字H20093636 | 0.125g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001020406908 | NHSA |
| 广东星昊药业有限公司 | 国药准字H20066441 | 0.5g | Category B (乙) | XJ01FAA051B001030100198 | NHSA |
| 上海上药新亚药业有限公司 | 国药准字H20056283 | 0.5g(按C38H72N2012计 ) | Category B (乙) | XJ01FAA051B001030100792 | NHSA |
| 江苏金丝利药业股份有限公司 | 国药准字H20030164 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001030101459 | NHSA |
| 南京圣和药业股份有限公司 | 国药准字H20213559 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001030101583 | NHSA |
| 湖北潜龙药业有限公司 | 国药准字H20000358 | 0.125g(12.5万单位) | Category B (乙) | XJ01FAA051B001030101841 | NHSA |
| 峨眉山通惠制药有限公司 | 国药准字H20066566 | 0.5g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001030102092 | NHSA |
| 西安利君制药有限责任公司 | 国药准字H20000377 | 0.125g(12.5万单位) | Category B (乙) | XJ01FAA051B001030102503 | NHSA |
| 石家庄四药有限公司 | 国药准字H20067807 | 0.5g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001030102557 | NHSA |
| 河南辅仁怀庆堂制药有限公司 | 国药准字H20020530 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B001030103021 | NHSA |
| 开封康诺药业有限公司 | 国药准字H20065173 | 0.5g(50万单位) | Category B (乙) | XJ01FAA051B001030103134 | NHSA |
| 齐鲁制药有限公司 | 国药准字H20237135 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001030104021 | NHSA |
| 安徽省先锋制药有限公司 | 国药准字H20073807 | 0.5g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001030104339 | NHSA |
| 杭州国光药业股份有限公司 | 国药准字H20073624 | 0.5g(50万单位) | Category B (乙) | XJ01FAA051B001030104478 | NHSA |
| 浙江贝得药业有限公司 | 国药准字H20073770 | 按C38H72N2O12计 0.5g | Category B (乙) | XJ01FAA051B001030104612 | NHSA |
| 浙江亚太药业股份有限公司 | 国药准字H20063286 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001030104744 | NHSA |
| 湖南恒生制药股份有限公司 | 国药准字H20066937 | 0.25g按C38H72N2O12计 | Category B (乙) | XJ01FAA051B001030104900 | NHSA |
| 海南葫芦娃药业集团股份有限公司 | 国药准字H20064932 | 0.5g(按C₃₈H₇₂N₂0₁₂计) | Category B (乙) | XJ01FAA051B001030105754 | NHSA |
| 海南倍特药业有限公司 | 国药准字H20067075 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001030105791 | NHSA |
| 康芝药业股份有限公司 | 国药准字H20067870 | 0.5g(25万单位) | Category B (乙) | XJ01FAA051B001030105844 | NHSA |
| 四川宏明博思药业有限公司 | 国药准字H20093666 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B001030106725 | NHSA |
| 南京海纳制药有限公司 | 国药准字H20093637 | 0.25g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001030106908 | NHSA |
| 广东星昊药业有限公司 | 国药准字H20066441 | 0.5g | Category B (乙) | XJ01FAA051B001030200198 | NHSA |
| 上海上药新亚药业有限公司 | 国药准字H20056283 | 0.5g(按C38H72N2012计 ) | Category B (乙) | XJ01FAA051B001030200792 | NHSA |
| 江苏金丝利药业股份有限公司 | 国药准字H20030164 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001030201459 | NHSA |
| 南京圣和药业股份有限公司 | 国药准字H20213559 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001030201583 | NHSA |
| 湖北潜龙药业有限公司 | 国药准字H20000358 | 0.125g(12.5万单位) | Category B (乙) | XJ01FAA051B001030201841 | NHSA |
| 峨眉山通惠制药有限公司 | 国药准字H20066566 | 0.5g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001030202092 | NHSA |
| 西安利君制药有限责任公司 | 国药准字H20000377 | 0.125g(12.5万单位) | Category B (乙) | XJ01FAA051B001030202503 | NHSA |
| 河南辅仁怀庆堂制药有限公司 | 国药准字H20020530 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B001030203021 | NHSA |
| 开封康诺药业有限公司 | 国药准字H20065173 | 0.5g(50万单位) | Category B (乙) | XJ01FAA051B001030203134 | NHSA |
| 齐鲁制药有限公司 | 国药准字H20237135 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001030204021 | NHSA |
| 安徽省先锋制药有限公司 | 国药准字H20073807 | 0.5g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001030204339 | NHSA |
| 浙江贝得药业有限公司 | 国药准字H20073770 | 按C38H72N2O12计 0.5g | Category B (乙) | XJ01FAA051B001030204612 | NHSA |
| 湖南恒生制药股份有限公司 | 国药准字H20066937 | 0.25g按C38H72N2O12计 | Category B (乙) | XJ01FAA051B001030204900 | NHSA |
| 海南葫芦娃药业集团股份有限公司 | 国药准字H20064932 | 0.5g(按C₃₈H₇₂N₂0₁₂计) | Category B (乙) | XJ01FAA051B001030205754 | NHSA |
| 海南海灵化学制药有限公司 | 国药准字H20020254 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001030205776 | NHSA |
| 海南倍特药业有限公司 | 国药准字H20067075 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001030205791 | NHSA |
| 南京海纳制药有限公司 | 国药准字H20093637 | 0.25g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001030206908 | NHSA |
| 江苏金丝利药业股份有限公司 | 国药准字H20030164 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001030301459 | NHSA |
| 河南辅仁怀庆堂制药有限公司 | 国药准字H20020530 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B001030303021 | NHSA |
| 开封康诺药业有限公司 | 国药准字H20065173 | 0.5g(50万单位) | Category B (乙) | XJ01FAA051B001030303134 | NHSA |
| 海南海灵化学制药有限公司 | 国药准字H20020254 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001030305776 | NHSA |
| 南京海纳制药有限公司 | 国药准字H20093637 | 0.25g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001030306908 | NHSA |
| 江苏金丝利药业股份有限公司 | 国药准字H20030164 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001030401459 | NHSA |
| 河南辅仁怀庆堂制药有限公司 | 国药准字H20020530 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B001030403021 | NHSA |
| 海南海灵化学制药有限公司 | 国药准字H20020254 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001030405776 | NHSA |
| 南京海纳制药有限公司 | 国药准字H20093637 | 0.25g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001030406908 | NHSA |
| 海南海灵化学制药有限公司 | 国药准字H20020254 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001030505776 | NHSA |
| 上海上药新亚药业有限公司 | 国药准字H20056283 | 0.5g(按C38H72N2012计 ) | Category B (乙) | XJ01FAA051B001040100792 | NHSA |
| 湖北潜龙药业有限公司 | 国药准字H20044550 | 0.5g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001040101841 | NHSA |
| 石家庄四药有限公司 | 国药准字H20067808 | 0.25g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001040102557 | NHSA |
| 杭州澳亚生物技术股份有限公司 | 国药准字H19990389 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B001040104470 | NHSA |
| 浙江亚太药业股份有限公司 | 国药准字H20063284 | 0.25g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001040104744 | NHSA |
| 湖南科伦制药有限公司 | 国药准字H20063421 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001040105006 | NHSA |
| 海南海灵化学制药有限公司 | 国药准字H20000082 | 0.125g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001040105776 | NHSA |
| 海南倍特药业有限公司 | 国药准字H20067073 | 0.125g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001040105791 | NHSA |
| 湖北潜龙药业有限公司 | 国药准字H20044550 | 0.5g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001040201841 | NHSA |
| 武汉华龙生物制药有限公司 | 国药准字H20065083 | 0.25g | Category B (乙) | XJ01FAA051B001040201940 | NHSA |
| 海南海灵化学制药有限公司 | 国药准字H20000082 | 0.125g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001040205776 | NHSA |
| 海南倍特药业有限公司 | 国药准字H20067073 | 0.125g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001040205791 | NHSA |
| 武汉华龙生物制药有限公司 | 国药准字H20065083 | 0.25g | Category B (乙) | XJ01FAA051B001040301940 | NHSA |
| 湖北潜龙药业有限公司 | 国药准字H20044550 | 0.5g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001050101841 | NHSA |
| 武汉华龙生物制药有限公司 | 国药准字H20065082 | 0.125g | Category B (乙) | XJ01FAA051B001050101940 | NHSA |
| 浙江亚太药业股份有限公司 | 国药准字H20063286 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001050104744 | NHSA |
| 湖南科伦制药有限公司 | 国药准字H20073092 | 按C₃₈H₇₂N₂O₁₂计0.125g | Category B (乙) | XJ01FAA051B001050105006 | NHSA |
| 海南海灵化学制药有限公司 | 国药准字H20000083 | 0.25g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001050105776 | NHSA |
| 海南倍特药业有限公司 | 国药准字H20066155 | 按C₃₈H₇₂N₂O₁₂计0.1g | Category B (乙) | XJ01FAA051B001050105791 | NHSA |
| 海南斯达制药有限公司 | 国药准字H20254211 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001050105816 | NHSA |
| 武汉华龙生物制药有限公司 | 国药准字H20065082 | 0.125g | Category B (乙) | XJ01FAA051B001050201940 | NHSA |
| 海南海灵化学制药有限公司 | 国药准字H20000083 | 0.25g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B001050205776 | NHSA |
| 海南斯达制药有限公司 | 国药准字H20254211 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001050205816 | NHSA |
| 武汉华龙生物制药有限公司 | 国药准字H20065084 | 0.5g | Category B (乙) | XJ01FAA051B001060101940 | NHSA |
| 浙江亚太药业股份有限公司 | 国药准字H20063285 | 0.125g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001060104744 | NHSA |
| 海南倍特药业有限公司 | 国药准字H20067074 | 0.25g (按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B001060105791 | NHSA |
| 武汉华龙生物制药有限公司 | 国药准字H20065084 | 0.5g | Category B (乙) | XJ01FAA051B001060201940 | NHSA |
| 成都天台山制药股份有限公司 | 国药准字H20064771 | 0.125g(12.5万单位) | Category B (乙) | XJ01FAA051B003010102066 | NHSA |
| 四川百利药业有限责任公司 | 国药准字H20113073 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B003010102120 | NHSA |
| 成都天台山制药股份有限公司 | 国药准字H20064771 | 0.125g(12.5万单位) | Category B (乙) | XJ01FAA051B003010202066 | NHSA |
| 四川百利药业有限责任公司 | 国药准字H20113073 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B003010202120 | NHSA |
| 成都天台山制药股份有限公司 | 国药准字H20064850 | 0.25g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B003020102066 | NHSA |
| 成都天台山制药股份有限公司 | 国药准字H20064850 | 0.25g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B003020202066 | NHSA |
| 成都天台山制药股份有限公司 | 国药准字H20064851 | 0.5g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B003030102066 | NHSA |
| 成都天台山制药股份有限公司 | 国药准字H20064851 | 0.5g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B003030202066 | NHSA |
| 悦康药业集团股份有限公司 | 国药准字H20094018 | 按C38H72N2O12计0.125g | Category B (乙) | XJ01FAA051B014010100239 | NHSA |
| 东北制药集团沈阳第一制药有限公司 | 国药准字H20000197 | 按阿奇霉素计0.125g(12.5万单位) | Category B (乙) | XJ01FAA051B014010101161 | NHSA |
| 西安迪赛生物药业有限责任公司 | 国药准字H20065057 | 0.25g | Category B (乙) | XJ01FAA051B014010102470 | NHSA |
| 山东罗欣药业集团股份有限公司 | 国药准字H20065405 | 0.125g(12.5万单位) | Category B (乙) | XJ01FAA051B014010104141 | NHSA |
| 瑞阳制药股份有限公司 | 国药准字H20066473 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B014010104152 | NHSA |
| 浙江金华康恩贝生物制药有限公司 | 国药准字H20030122 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B014010104656 | NHSA |
| 浙江普洛康裕制药有限公司 | 国药准字H20020339 | 0.5g(50万单位阿奇霉素,以C38H72N2O12计) | Category B (乙) | XJ01FAA051B014010104685 | NHSA |
| 悦康药业集团股份有限公司 | 国药准字H20094018 | 按C38H72N2O12计0.125g | Category B (乙) | XJ01FAA051B014010200239 | NHSA |
| 东北制药集团沈阳第一制药有限公司 | 国药准字H20000197 | 按阿奇霉素计0.125g(12.5万单位) | Category B (乙) | XJ01FAA051B014010201161 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20066776 | 0.125g(12.5万单位) | Category B (乙) | XJ01FAA051B014010204127 | NHSA |
| 山东罗欣药业集团股份有限公司 | 国药准字H20065405 | 0.125g(12.5万单位) | Category B (乙) | XJ01FAA051B014010204141 | NHSA |
| 瑞阳制药股份有限公司 | 国药准字H20066473 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B014010204152 | NHSA |
| 国药集团国瑞药业有限公司 | 国药准字H20010189 | 0.25g | Category B (乙) | XJ01FAA051B014010204383 | NHSA |
| 浙江普洛康裕制药有限公司 | 国药准字H20020339 | 0.5g(50万单位阿奇霉素,以C38H72N2O12计) | Category B (乙) | XJ01FAA051B014010204685 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20066776 | 0.125g(12.5万单位) | Category B (乙) | XJ01FAA051B014010304127 | NHSA |
| 瑞阳制药股份有限公司 | 国药准字H20066473 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B014010304152 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20066776 | 0.125g(12.5万单位) | Category B (乙) | XJ01FAA051B014010404127 | NHSA |
| 瑞阳制药股份有限公司 | 国药准字H20066473 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B014010404152 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20066776 | 0.125g(12.5万单位) | Category B (乙) | XJ01FAA051B014010504127 | NHSA |
| 瑞阳制药股份有限公司 | 国药准字H20066473 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B014010504152 | NHSA |
| 悦康药业集团股份有限公司 | 国药准字H20094019 | 按C38H72N2O12计0.25g | Category B (乙) | XJ01FAA051B014020100239 | NHSA |
| 西安迪赛生物药业有限责任公司 | 国药准字H20065058 | 0.50g | Category B (乙) | XJ01FAA051B014020102470 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20066777 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B014020104127 | NHSA |
| 山东罗欣药业集团股份有限公司 | 国药准字H20065406 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B014020104141 | NHSA |
| 瑞阳制药股份有限公司 | 国药准字H20066472 | 0.5g(50万单位) | Category B (乙) | XJ01FAA051B014020104152 | NHSA |
| 浙江普洛康裕制药有限公司 | 国药准字H20020338 | 0.25g(25万单位阿奇霉素,以C36H72N2O12计) | Category B (乙) | XJ01FAA051B014020104685 | NHSA |
| 悦康药业集团股份有限公司 | 国药准字H20094019 | 按C38H72N2O12计0.25g | Category B (乙) | XJ01FAA051B014020200239 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20066777 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B014020204127 | NHSA |
| 山东罗欣药业集团股份有限公司 | 国药准字H20065406 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B014020204141 | NHSA |
| 瑞阳制药股份有限公司 | 国药准字H20066472 | 0.5g(50万单位) | Category B (乙) | XJ01FAA051B014020204152 | NHSA |
| 国药集团国瑞药业有限公司 | 国药准字H20030269 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B014020204383 | NHSA |
| 浙江普洛康裕制药有限公司 | 国药准字H20020338 | 0.25g(25万单位阿奇霉素,以C36H72N2O12计) | Category B (乙) | XJ01FAA051B014020204685 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20066777 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B014020304127 | NHSA |
| 瑞阳制药股份有限公司 | 国药准字H20066472 | 0.5g(50万单位) | Category B (乙) | XJ01FAA051B014020304152 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20066777 | 0.25g(25万单位) | Category B (乙) | XJ01FAA051B014020404127 | NHSA |
| 瑞阳制药股份有限公司 | 国药准字H20066472 | 0.5g(50万单位) | Category B (乙) | XJ01FAA051B014020404152 | NHSA |
| 瑞阳制药股份有限公司 | 国药准字H20066472 | 0.5g(50万单位) | Category B (乙) | XJ01FAA051B014020504152 | NHSA |
| 悦康药业集团股份有限公司 | 国药准字H20094017 | 0.5g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B014030100239 | NHSA |
| 山东罗欣药业集团股份有限公司 | 国药准字H20065407 | 0.5g(50万单位) | Category B (乙) | XJ01FAA051B014030104141 | NHSA |
| 悦康药业集团股份有限公司 | 国药准字H20094017 | 0.5g(按C38H72N2O12计) | Category B (乙) | XJ01FAA051B014030200239 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20066778 | 0.5g(50万单位) | Category B (乙) | XJ01FAA051B014030204127 | NHSA |
| 国药集团国瑞药业有限公司 | 国药准字H20030108 | 125mg | Category B (乙) | XJ01FAA051B014030204383 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20066778 | 0.5g(50万单位) | Category B (乙) | XJ01FAA051B014030304127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20066778 | 0.5g(50万单位) | Category B (乙) | XJ01FAA051B014030404127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20066778 | 0.5g(50万单位) | Category B (乙) | XJ01FAA051B014030504127 | NHSA |
| 山东罗欣药业集团股份有限公司 | 国药准字H20065407 | 0.5g(50万单位) | Category B (乙) | XJ01FAA051B014040104141 | NHSA |
| 国药集团国瑞药业有限公司 | 国药准字H20030269 | 0.5g(按C₃₈H₇₂N₂O₁₂计) | Category B (乙) | XJ01FAA051B014040104383 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 11 filings and 9 distinct first applicants.
Supplement 8 · Generic 3
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 西安利君制药有限责任公司 | CYHB2650206 | Supplement | 2026/10/19 | Not stated by source | CDE |
| 西安利君制药有限责任公司 | CYHB2650205 | Supplement | 2026/10/19 | Not stated by source | CDE |
| 上海上药新亚药业有限公司 | CYHB2601732 | Supplement | 2026/09/15 | Not stated by source | CDE |
| 辰欣药业股份有限公司 | CYHB2650165 | Supplement | 2026/07/23 | Not stated by source | CDE |
| 武汉市小铂生物科技有限公司;湖北长联杜勒制药有限公司 | CYHS2601531 | Generic | 2026/06/29 | Not stated by source | CDE |
| 国药集团国瑞药业有限公司 | CYHB2601051 | Supplement | 2026/06/04 | Not stated by source | CDE |
| 国药集团国瑞药业有限公司 | CYHB2601050 | Supplement | 2026/06/04 | Not stated by source | CDE |
| 湖北潜龙药业有限公司 | CYHB2600288 | Supplement | 2026/02/10 | Not stated by source | CDE |
| 广东金城金素制药有限公司;广东隆赋药业股份有限公司 | CYHS2600218 | Generic | 2026/01/20 | Not stated by source | CDE |
| 重庆药友制药有限责任公司 | CYHS2503769 | Generic | 2025/10/23 | Not stated by source | CDE |
| 湖北午时药业股份有限公司 | CYHB2650210 | Supplement | 2026/10/26 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 2 filings and 2 distinct first applicants.
API registrations
Non-component matches: 34 companies with A status and 4 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 阿奇霉素 | 浙江金华康恩贝生物制药有限公司 | Y20260000882 | I | Exact ingredient | 2026/10/21 | CDE |
| 阿奇霉素 | Pharmagen Ltd. | Y20250000419 | I | Exact ingredient | 2025/07/11 | CDE |
| 阿奇霉素 | Alembic Pharmaceuticals Limited | Y20240000887 | A | Exact ingredient | 2026/09/03 | CDE |
| 阿奇霉素 | 宁夏泰益欣生物科技股份有限公司 | Y20210000368 | A | Exact ingredient | 2026/03/02 | CDE |
| 阿奇霉素 | Pfizer Asia Manufacturing Pte Ltd | Y20200001087 | A | Exact ingredient | 2024/09/10 | CDE |
| 阿奇霉素 | 湖南九典宏阳制药有限公司 | Y20180001793 | A | Exact ingredient | 2023/10/17 | CDE |
| 阿奇霉素 | TAPI Croatia Industries Ltd. | Y20190009959 | A | Exact ingredient | 2025/10/30 | CDE |
| 阿奇霉素 | 浙江国邦药业有限公司 | Y20190009898 | A | Exact ingredient | 2024/07/03 | CDE |
| 阿奇霉素 | 石药集团欧意药业有限公司 | Y20190009555 | A | Exact ingredient | 2024/07/09 | CDE |
| 阿奇霉素 | Pfizer Inc. | Y20190009141 | A | Exact ingredient | 2024/11/12 | CDE |
| 阿奇霉素 | 江苏威奇达药业有限公司 | Y20190008874 | A | Exact ingredient | 2026/08/06 | CDE |
| 阿奇霉素 | 黄石世星药业有限责任公司 | Y20190008850 | A | Exact ingredient | 2026/02/07 | CDE |
| 阿奇霉素 | 浙江震元制药有限公司 | Y20190007600 | A | Exact ingredient | 2024/06/12 | CDE |
| 阿奇霉素 | 开封制药（集团）有限公司 | Y20190006536 | A | Exact ingredient | 2025/07/23 | CDE |
| 阿奇霉素 | 天方药业有限公司 | Y20190006317 | A | Exact ingredient | 2024/11/01 | CDE |
| 阿奇霉素 | 宁夏启元药业有限公司 | Y20190006173 | A | Exact ingredient | 2026/03/19 | CDE |
| 阿奇霉素 | 西安利君制药有限责任公司 | Y20190005668 | A | Exact ingredient | 2026/01/07 | CDE |
| 阿奇霉素 | 北京太洋药业股份有限公司 | Y20190005484 | A | Exact ingredient | — | CDE |
| 阿奇霉素 | 宜昌东阳光生化制药有限公司 | Y20190005339 | A | Exact ingredient | 2026/02/13 | CDE |
| 阿奇霉素 | 河北东风药业有限公司 | Y20190004976 | A | Exact ingredient | 2025/02/09 | CDE |
| 阿奇霉素 | 浙江贝得药业有限公司 | Y20190004814 | A | Exact ingredient | 2025/03/04 | CDE |
| 马来酸阿奇霉素 | 天津生物化学制药有限公司 | Y20190004393 | A | Salt-normalized ingredient | 2025/08/16 | CDE |
| 阿奇霉素 | 台山市化学制药有限公司 | Y20190004081 | A | Exact ingredient | — | CDE |
| 阿奇霉素 | 华北制药河北华民药业有限责任公司 | Y20190003842 | A | Exact ingredient | 2025/06/07 | CDE |
| 阿奇霉素 | 菏泽市方明制药有限公司 | Y20190003689 | A | Exact ingredient | — | CDE |
| 阿奇霉素 | 浙江耐司康药业有限公司 | Y20190003585 | A | Exact ingredient | 2025/07/05 | CDE |
| 阿奇霉素 | 浙江奥托康制药集团股份有限公司 | Y20190003518 | A | Exact ingredient | — | CDE |
| 阿奇霉素 | 浙江永宁药业股份有限公司 | Y20190003427 | A | Exact ingredient | 2024/12/10 | CDE |
| 盐酸阿奇霉素 | 南京长澳制药有限公司 | Y20190002838 | A | Salt-normalized ingredient | — | CDE |
| 硫酸阿奇霉素 | 浙江尖峰药业有限公司 | Y20190002579 | A | Salt-normalized ingredient | 2024/11/20 | CDE |
| 富马酸阿奇霉素 | 德州德药制药有限公司 | Y20190002300 | A | Salt-normalized ingredient | 2025/02/07 | CDE |
| 阿奇霉素 | 齐鲁制药有限公司 | Y20190001577 | A | Exact ingredient | — | CDE |
| 阿奇霉素 | 绍兴兴亚药业有限公司 | Y20190001524 | A | Exact ingredient | — | CDE |
| 阿奇霉素 | 四川江川制药有限公司 | Y20190001366 | A | Exact ingredient | — | CDE |
| 阿奇霉素 | 乳源东阳光药业有限公司 | Y20190000922 | A | Exact ingredient | 2023/08/14 | CDE |
| 阿奇霉素 | 石药集团欧意药业有限公司 | Y20190000443 | I | Exact ingredient | 2019/06/12 | CDE |
| 阿奇霉素 | PLIVA Croatia Ltd. | Y20180001512 | I | Exact ingredient | 2019/02/03 | CDE |
| 阿奇霉素 | 河北国龙制药有限公司 | Y20170000182 | A | Exact ingredient | 2024/10/24 | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/10 07:23. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
-
2026/10/26Accepted
-
2026/10/19Accepted
-
2026/10/19Accepted
-
2026/09/15Accepted
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/10 07:27
- Chemical-drug catalogue
- Last successful update: 2026/11/10 07:23
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/10 07:25
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31
First index-page publication dates: 2026-10-26 to 2026-11-10; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/10 08:10 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 3/30; discovered pending details: 20. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Azithromycin For Injection
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Yearly
US$1,920
Billed every year
US$160 per month
Online subscriptions are not enabled. The form below registers interest; it does not charge or activate access.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
US$490
One payment · 12 months of access
Online comparison-table purchase is not enabled.
Billed by Creem, our merchant of record · Terms · Refund policy